Which ETFs hold Regeneron Pharmaceuticals Inc (REGN)?
American biotech company known for the eye drug Eylea and immunology medicine Dupixent.
43 Australian ETFs hold Regeneron Pharmaceuticals Inc, a Health Care company from United States. HLTH has the biggest weighting at 2.23%. Across these funds, Australian ETF investors own about $200m of Regeneron Pharmaceuticals Inc.
The ETFs with the most Regeneron Pharmaceuticals Inc
All 43 ETFs that hold Regeneron Pharmaceuticals Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Regeneron Pharmaceuticals Inc.
Common questions
Which ETF has the most Regeneron Pharmaceuticals Inc?
HLTH (VanEck Global Healthcare Leaders ETF) has the highest weighting, with 2.23% of the fund in Regeneron Pharmaceuticals Inc.
What is the cheapest ETF that holds Regeneron Pharmaceuticals Inc?
Of the ETFs where Regeneron Pharmaceuticals Inc is at least 1% of the fund, IXJ has the lowest fee at 0.41% a year, with 1.02% in Regeneron Pharmaceuticals Inc.
How much Regeneron Pharmaceuticals Inc do I own with $10,000 in VGS?
About $9. VGS is the largest ETF that holds Regeneron Pharmaceuticals Inc, and Regeneron Pharmaceuticals Inc makes up 0.09% of it.
How many Australian ETFs hold Regeneron Pharmaceuticals Inc?
43 ETFs listed on the ASX or TMX Australia hold Regeneron Pharmaceuticals Inc, based on issuers' published holdings.